Company: CVCO
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001628280-25-047849
Chunk: 49

Company: CAVCO INDUSTRIES, INC.
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 8
Chunk 49
---
01"). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Both early adoption and retrospective application are permitted. The Company is currently evaluating the impact that the adoption of these standards will have on its Consolidated Financial Statements.

3. Revenue from Contracts with Customers

The following table summarizes Net revenue disaggregated by reportable segment and source (in thousands):Three Months EndedSix Months Ended September 27, 2025September 28, 2024September 27,2025September 28,2024Factory-built housing     Home sales$509,750 $469,676 $1,019,486 $906,105      Delivery, setup and other revenues25,367 16,667 51,325 38,286 535,117 486,343 1,070,811 944,391 Financial services     Insurance agency commissions received from third-party insurance companies1,514 1,268 2,924 2,674      All other sources19,896 19,850 39,649 37,995 21,410 21,118 42,573 40,669 $556,527 $507,461 $1,113,384 $985,060 

4. Cash and Cash Equivalents and Restricted Cash

The following table provides a reconciliation of Cash and cash equivalents and Restricted cash reported within the Consolidated Balance Sheets to the combined amounts shown in the Consolidated Statements of Cash Flows (in thousands):September 27,2025September 28,2024Cash and cash equivalents$374,978 $364,113 Restricted cash, current24,391 21,519 Restricted cash585 585 $399,954 $386,217 

5

5. Investments

Investments consisted of the following (in thousands):September 27,2025March 29,2025Available-for-sale debt securities$23,197 $21,415 Marketable equity securities12,859 11,425 Non-marketable equity investments5,